Biologics

Spinal Implants

Xtant Medical Highlights Growing Product Portfolio at NASS 2023

BELGRADE, Mont. , Oct. 12, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products